GB201119401D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number: GB201119401D0
Authority: GB; United Kingdom
Prior art keywords: therapeutic agents; therapeutic; agents
Prior art date: 2011-11-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1119401.6A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Katholieke Universiteit Leuven

UCB SA

Original Assignee

Katholieke Universiteit Leuven

UCB SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-11-10

Filing date

2011-11-10

Publication date

2011-12-21

2011-11-10 Application filed by Katholieke Universiteit Leuven, UCB SA filed Critical Katholieke Universiteit Leuven

2011-11-10 Priority to GBGB1119401.6A priority Critical patent/GB201119401D0/en

2011-12-21 Publication of GB201119401D0 publication Critical patent/GB201119401D0/en

2012-11-08 Priority to EP12801466.9A priority patent/EP2776445B1/en

2012-11-08 Priority to ES12801466.9T priority patent/ES2599252T3/en

2012-11-08 Priority to PCT/EP2012/072130 priority patent/WO2013068458A1/en

2012-11-08 Priority to US14/357,340 priority patent/US9096614B2/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

GBGB1119401.6A 2011-11-10 2011-11-10 Therapeutic agents Ceased GB201119401D0 (en)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
GBGB1119401.6A GB201119401D0 (en)	2011-11-10	2011-11-10	Therapeutic agents
EP12801466.9A EP2776445B1 (en)	2011-11-10	2012-11-08	Therapeutically active thiazolo-pyrimidine derivatives
ES12801466.9T ES2599252T3 (en)	2011-11-10	2012-11-08	Therapeutically active thiazolo-pyrimidine derivatives
PCT/EP2012/072130 WO2013068458A1 (en)	2011-11-10	2012-11-08	Therapeutically active thiazolo-pyrimidine derivatives
US14/357,340 US9096614B2 (en)	2011-11-10	2012-11-08	Therapeutically active thiazolo-pyrimidine derivatives

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1119401.6A GB201119401D0 (en)	2011-11-10	2011-11-10	Therapeutic agents

Publications (1)

Publication Number	Publication Date
GB201119401D0 true GB201119401D0 (en)	2011-12-21

Family

ID=45421557

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1119401.6A Ceased GB201119401D0 (en)	2011-11-10	2011-11-10	Therapeutic agents

Country Status (5)

Country	Link
US (1)	US9096614B2 (en)
EP (1)	EP2776445B1 (en)
ES (1)	ES2599252T3 (en)
GB (1)	GB201119401D0 (en)
WO (1)	WO2013068458A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201217704D0 (en) *	2012-10-03	2012-11-14	Ucb Pharma Sa	Therapeutic agents
CA2935880A1 (en)	2014-01-10	2015-07-16	Aurigene Discovery Technologies Limited	Indazole compounds as irak4 inhibitors
EP3466955B1 (en)	2014-01-13	2020-12-16	Aurigene Discovery Technologies Limited	Method of preparing oxazolo[4,5-b]pyridine and thiazolo[4,5-b]pyridine derivatives as irak4 inhibitors for treating cancer
GB201410817D0 (en) *	2014-06-17	2014-07-30	Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D	Therapeutic agents
GB201410816D0 (en)	2014-06-17	2014-07-30	Ucb Biopharma Sprl And Katholieke Universiteit Leuven	Therapeutic agents
EA201692418A1 (en) *	2014-06-20	2017-04-28	Ауриджен Дискавери Текнолоджиз Лимитед	SUBSTITUTE INDASOLIC COMPOUNDS AS IRAK4 INHIBITORS
GB201517263D0 (en)	2015-09-30	2015-11-11	Ucb Biopharma Sprl And Katholieke Universiteit Leuven	Therapeutic agents
GB201521767D0 (en) *	2015-12-10	2016-01-27	Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R&D	Therapeutic agents
JOP20180009A1 (en)	2017-02-06	2019-01-30	Gilead Sciences Inc	Hiv inhibitor compounds
BR112019018991A2 (en)	2017-03-31	2020-04-14	Aurigene Discovery Technologies Limited	compounds and compositions to treat hematological disorders
CN107188855A (en) *	2017-07-14	2017-09-22	常州工程职业技术学院	A kind of preparation method of the methoxyl group pyridazine of 3 amino 6
EP4410377A3 (en)	2017-10-31	2024-11-13	Curis, Inc.	Compounds and compositions for treating hematological disorders
PL3816164T3 (en)	2018-06-25	2024-08-12	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Isothiazolo[5,4-d]pyrimidine compound as irak4 inhibitor
CN111253321A (en) *	2019-09-12	2020-06-09	大连大学	Preparation method of 2-methoxy-5-amino-4-methylpyrimidine
US12178821B2 (en)	2021-04-08	2024-12-31	Curis, Inc.	Combination therapies for the treatment of cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2155963A1 (en) *	1971-11-11	1973-05-17	Thomae Gmbh Dr K	5,7-diamino-thiazolo(5,4-d)pyrimidines - with hypotensive and antithrombotic activity
BE791242A (en) *	1971-11-11	1973-05-10	Thomae Gmbh Dr K	NEWS THIAZOLO (5,4-D) PYRIMIDINES
SE9904738D0 (en) *	1999-12-22	1999-12-22	Astra Pharma Prod	Novel compounds
JP4862654B2 (en) *	2004-10-08	2012-01-25	アステラス製薬株式会社	Aromatic ring fused pyrimidine derivatives
US8088767B2 (en)	2006-09-28	2012-01-03	Exelixis, Inc.	JAK-2 modulators and methods of use
WO2008059368A2 (en) *	2006-11-17	2008-05-22	Pfizer Products Inc.	Fused 2-amino pyrimidine compounds and their use for the treatment of cancer
EP2158207B1 (en)	2007-06-12	2011-05-25	F. Hoffmann-La Roche AG	Thiazoliopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
JP5647998B2 (en)	2009-03-13	2015-01-07	カトリーケユニバーシテイトルーヴェン、ケー．ユー．ルーヴェンアールアンドディー	Thiazolopyrimidine modulators as immunosuppressants
GB201012889D0 (en)	2010-08-02	2010-09-15	Univ Leuven Kath	Antiviral activity of novel bicyclic heterocycles
GB201015411D0 (en)	2010-09-15	2010-10-27	Univ Leuven Kath	Anti-cancer activity of novel bicyclic heterocycles

2011
- 2011-11-10 GB GBGB1119401.6A patent/GB201119401D0/en not_active Ceased
2012
- 2012-11-08 US US14/357,340 patent/US9096614B2/en not_active Expired - Fee Related
- 2012-11-08 EP EP12801466.9A patent/EP2776445B1/en active Active
- 2012-11-08 WO PCT/EP2012/072130 patent/WO2013068458A1/en not_active Ceased
- 2012-11-08 ES ES12801466.9T patent/ES2599252T3/en active Active

Also Published As

Publication number	Publication date
EP2776445A1 (en)	2014-09-17
ES2599252T3 (en)	2017-01-31
US20140315885A1 (en)	2014-10-23
EP2776445B1 (en)	2016-08-10
WO2013068458A1 (en)	2013-05-16
US9096614B2 (en)	2015-08-04

Publication	Publication Date	Title
GB201212513D0 (en)	2012-08-29	Therapeutic agents
GB201114212D0 (en)	2011-10-05	Therapeutic agents
IL233756A0 (en)	2014-09-30	Novel therapeutic agents
ZA201305897B (en)	2014-04-30	Combination therapy
GB201119401D0 (en)	2011-12-21	Therapeutic agents
ZA201400120B (en)	2015-09-30	Combination therapy
ZA201403372B (en)	2017-08-30	Therapeutic agents and uses thereof
GB201217704D0 (en)	2012-11-14	Therapeutic agents
ZA201502595B (en)	2017-01-25	Therapeutic methods
PL2723344T3 (en)	2016-03-31	Monoterpene-containing agent for combination therapy
EP2704712A4 (en)	2014-10-15	Isoxazolines as therapeutic agents
EP2701744A4 (en)	2014-08-20	Combination therapy
PH12014501058A1 (en)	2014-06-23	Therapeutic agent for arthrosis
IL228589A0 (en)	2013-12-31	Therapeutic treatment
GB201102913D0 (en)	2011-04-06	Novel therapeutic
GB201115558D0 (en)	2011-10-26	Therapeutic agents
GB201110614D0 (en)	2011-08-03	Therapeutic agents
GB201101128D0 (en)	2011-03-09	Therapeutic agents
GB201110895D0 (en)	2011-08-10	Therapeutic use
GB201223021D0 (en)	2013-02-06	Therapeutic agents
GB201212512D0 (en)	2012-08-29	Therapeutic agents
GB201210233D0 (en)	2012-07-25	Therapeutic agents
GB201114226D0 (en)	2011-10-05	Combination therapy
ZA201405764B (en)	2017-09-27	Novel therapeutic agents
GB201014963D0 (en)	2010-10-20	Therapeutic agents

Legal Events

Date	Code	Title	Description
2013-05-08	AT	Applications terminated before publication under section 16(1)